GZMB and cancer: The expression of GrB-PBMC in patients with malignant tumors (1650; 663–3260 pg/mg protein, median, interquartile range) was reduced as compared to the group with nonmalignant lesions (5240; 2160–7440 pg/mg protein, p = 0.0003, Mann–Whitney test, Fig. 1b).